Adipose Stromal Cells Repair Pressure Ulcers in Both Young and Elderly Mice: Potential Role of Adipogenesis in Skin Repair
Tóm tắt
More than 2.5 million patients in the U.S. require treatment for pressure ulcers annually, and the elderly are at particularly high risk for pressure ulcer development. Current therapy for pressure ulcers consists of conservative medical management for shallow lesions and aggressive debridement and surgery for deeper lesions. The current study uses a murine model to address the hypothesis that adipose-derived stromal/stem cell (ASC) treatment would accelerate and enhance pressure ulcer repair. The dorsal skin of both young (2 months old [mo]) and old (20 mo) C57BL/6J female mice was sandwiched between external magnets for 12 hours over 2 consecutive days to initiate a pressure ulcer. One day following the induction, mice were injected with ASCs isolated from congenic mice transgenic for the green fluorescent protein under a ubiquitous promoter. Relative to phosphate-buffered saline-treated controls, ASC-treated mice displayed a cell concentration-dependent acceleration of wound closure, improved epidermal/dermal architecture, increased adipogenesis, and reduced inflammatory cell infiltration. The ASC-induced improvements occurred in both young and elderly recipients, although the expression profile of angiogenic, immunomodulatory, and reparative mRNAs differed as a function of age. The results are consistent with clinical reports that fat grafting improved skin architecture in thermal injuries; the authors of this published study have invoked ASC-based mechanisms to account for their clinical outcomes. Thus, the current proof-of-principle study sets the stage for clinical translation of autologous and/or allogeneic ASC treatment of pressure ulcers.
Adipose-derived stromal/stem cells (ASCs) promote the healing of pressure ulcer wounds in both young and old mice. ASCs enhance wound healing rates through adipogenic differentiation and regeneration of the underlying architecture of the skin.
Từ khóa
Tài liệu tham khảo
White-Chu, 2011, Pressure ulcers in long-term care, Clin Geriatr Med, 27, 241, 10.1016/j.cger.2011.02.001
Wyndaele, 2006, Incidence, prevalence and epidemiology of spinal cord injury: What learns a worldwide literature survey?, Spinal Cord, 44, 523, 10.1038/sj.sc.3101893
Krause, 2009, Risk of mortality after spinal cord injury: An 8-year prospective study, Arch Phys Med Rehabil, 90, 1708, 10.1016/j.apmr.2009.04.020
Cao, 2013, Risk factors for mortality after spinal cord injury in the USA, Spinal Cord, 51, 413, 10.1038/sc.2013.2
Black, 2007, National Pressure Ulcer Advisory Panel's updated pressure ulcer staging system, Urol Nurs, 27, 144
Clemens, 2010, Innovation and management of diabetic foot wounds, Surg Technol Int, 20, 61
Clemens, 2008, Biological basis of diabetic foot wounds, Surg Technol Int, 17, 89
Xie, 2010, The clinical effectiveness of negative pressure wound therapy: A systematic review, J Wound Care, 19, 490, 10.12968/jowc.2010.19.11.79697
Cushing, 2013, Evidence-based medicine: Pressure sores, Plast Reconstr Surg, 132, 1720, 10.1097/PRS.0b013e3182a808ba
Nguyen, 2008, A literature review of different pressure ulcer models from 1942–2005 and the development of an ideal animal model, Australas Phys Eng Sci Med, 31, 223, 10.1007/BF03179348
Peirce, 2000, Ischemia-reperfusion injury in chronic pressure ulcer formation: A skin model in the rat, Wound Repair Regen, 8, 68, 10.1046/j.1524-475x.2000.00068.x
Bouten, 2003, The etiology of pressure ulcers: Skin deep or muscle bound?, Arch Phys Med Rehabil, 84, 616, 10.1053/apmr.2003.50038
Wu, 2007, Bone marrow-derived stem cells in wound healing: A review, Wound Repair Regen, 15, S18, 10.1111/j.1524-475X.2007.00221.x
Stadler, 2004, Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse, J Invest Surg, 17, 221, 10.1080/08941930490472046
Demiot, 2011, Erythropoietin restores C-fiber function and prevents pressure ulcer formation in diabetic mice, J Invest Dermatol, 131, 2316, 10.1038/jid.2011.211
Park, 2009, Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF, Acta Biomater, 5, 1926, 10.1016/j.actbio.2009.03.002
Saito, 2008, The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer, J Invest Dermatol, 128, 1838, 10.1038/sj.jid.5701258
Tong, 2011, Heparan sulfate glycosaminoglycan mimetic improves pressure ulcer healing in a rat model of cutaneous ischemia-reperfusion injury, Wound Repair Regen, 19, 505, 10.1111/j.1524-475X.2011.00704.x
Wassermann, 2009, A chronic pressure ulcer model in the nude mouse, Wound Repair Regen, 17, 480, 10.1111/j.1524-475X.2009.00502.x
Schatteman, 2006, Old bone marrow cells inhibit skin wound vascularization, Stem Cells, 24, 717, 10.1634/stemcells.2005-0214
Gimble, 2007, Adipose-derived stem cells for regenerative medicine, Circ Res, 100, 1249, 10.1161/01.RES.0000265074.83288.09
Nayeri, 2006, Autocrine production of biologically active hepatocyte growth factor (HGF) by injured human skin, J Dermatol Sci, 43, 49, 10.1016/j.jdermsci.2006.03.004
Amos, 2010, Human adipose-derived stromal cells accelerate diabetic wound healing: Impact of cell formulation and delivery, Tissue Eng Part A, 16, 1595, 10.1089/ten.tea.2009.0616
Kilroy, 2007, Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and pro-inflammatory factors, J Cell Physiol, 212, 702, 10.1002/jcp.21068
Yu, 2010, Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes, Cytotherapy, 12, 538, 10.3109/14653241003649528
Staszkiewicz, 2010, Cell growth characteristics, differentiation frequency, and immunophenotype of adult ear mesenchymal stem cells, Stem Cells Dev, 19, 83, 10.1089/scd.2009.0051
Strong, 2015, Characterization of a murine pressure ulcer model to assess the regenerative potential of adipose-derived stromal cells, Plast Reconstr Surg GO, 3, e334, 10.1097/GOX.0000000000000260
Woodbury, 2004, Prevalence of pressure ulcers in Canadian healthcare settings, Ostomy Wound Manage, 50, 22
Bourin, 2013, Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT), Cytotherapy, 15, 641, 10.1016/j.jcyt.2013.02.006
McIntosh, 2013, Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics, Expert Rev Clin Immunol, 9, 175, 10.1586/eci.12.96
Pachón-Peña, 2011, Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles, J Cell Physiol, 226, 843, 10.1002/jcp.22408
Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905
de la Garza-Rodea, 2011, Pressure ulcers: Description of a new model and use of mesenchymal stem cells for repair, Dermatology, 223, 266, 10.1159/000334628
Gimble, 2011, Concise review: Adipose-derived stromal vascular fraction cells and stem cells: Let's not get lost in translation, Stem Cells, 29, 749, 10.1002/stem.629
Gimble, 2010, Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells, Stem Cell Res Ther, 1, 19, 10.1186/scrt19
Mesimäki, 2009, Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells, Int J Oral Maxillofac Surg, 38, 201, 10.1016/j.ijom.2009.01.001
Sándor, 2014, Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects, Stem Cells Translational Medicine, 3, 530, 10.5966/sctm.2013-0173
Thesleff, 2011, Cranioplasty with adipose-derived stem cells and biomaterial: A novel method for cranial reconstruction, Neurosurgery, 68, 1535, 10.1227/NEU.0b013e31820ee24e
Bura, 2014, Phase I trial: The use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia, Cytotherapy, 16, 245, 10.1016/j.jcyt.2013.11.011
Kurtzberg, 2014, Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients, Biol Blood Marrow Transplant, 20, 229, 10.1016/j.bbmt.2013.11.001
Scruggs, 2013, Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model, Stem Cells Translational Medicine, 2, 797, 10.5966/sctm.2013-0026
Zhang, 2014, Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model, PLoS One, 9, e85007, 10.1371/journal.pone.0085007
Cianfarani, 2013, Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing, Wound Repair Regen, 21, 545, 10.1111/wrr.12051
Driskell, 2011, Hair follicle dermal papilla cells at a glance, J Cell Sci, 124, 1179, 10.1242/jcs.082446
Schmidt, 2013, Intradermal adipocytes mediate fibroblast recruitment during skin wound healing, Development, 140, 1517, 10.1242/dev.087593